GLP-1 medicines may do more than manage diabetes - new research shows they can cut clot-related risks and mortality in people with obesity and autoimmune disease. ⚡️🔬 www.news-medical.net/news/2026061... #GLP1 #AutoimmuneDisease #Cardiology
www.news-medical.net
In a target trial emulation using OneFlorida+ electronic health record data, GLP-1 receptor agonist use in adults with obesity and autoimmune disease was linked to lower hazards of pulmonary embolism,...